# Role of ARNi in Ventricular Remodeling in Hypertensive LVH

> **NCT03553810** · PHASE2 · COMPLETED · sponsor: **National Heart Centre Singapore** · enrollment: 80 (actual)

## Conditions studied

- Hypertensive Heart Disease

## Interventions

- **DRUG:** Entresto
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT03553810
- **Lead sponsor:** National Heart Centre Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-12
- **Primary completion:** 2024-06-28
- **Final completion:** 2024-06-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03553810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03553810, "Role of ARNi in Ventricular Remodeling in Hypertensive LVH". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03553810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*